FX Newsletter | December 2023
Wrapping up 2023 and a look at what's on our horizon for 2024! Our research study on Adults/Ageing and Fragile X syndrome. The Zynerba RECONNECT clinical trial extended to March 2024. Our webinar program for 2024. Disability Expos 2024. Congratulating the FXAA Achievement and Volunteer Award winners for 2023. And profiling online learning modules about intellectual disability & mental health; and sensory sensitivities in Fragile X syndrome.
News